LBLTF (Lattice Biologics) Total Operating Expense: $0.99 Mil (TTM As of Jun. 2021)


What is Lattice Biologics Total Operating Expense?

Lattice Biologics LBLTF -99.00% Total Operating Expense is $0.99 Mil as of Jun. 2021.

Lattice Biologics's Total Operating Expense for the three months ended in Jun. 2021 was $0.03 Mil. Lattice Biologics's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2021 was $0.99 Mil.

Lattice Biologics Total Operating Expense Related Terms

Lattice Biologics Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Lattice Biologics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lattice Biologics Total Operating Expense Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.27 3.39 2.03 1.53 1.29

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.22 0.35 0.39 0.03

Lattice Biologics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.99 Mil mean?
Lattice Biologics (LBLTF) has a Total Operating Expense of $0.99 Mil as of Jun. 2021. Total operating expense is the primary recurring expense associated with central operations. View historical data on Lattice Biologics and its competitors.
Is Lattice Biologics' Total Operating Expense too high?
Lattice Biologics' current Total Operating Expense is $0.99 Mil.
How does Lattice Biologics' Total Operating Expense compare to ABT and MDT?
Lattice Biologics' Total Operating Expense of $0.99 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Lattice Biologics and its competitors. Lattice Biologics's current Total Operating Expense is $0.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lattice Biologics stock overvalued right now?
Lattice Biologics (LBLTF) has a current Total Operating Expense of $0.99 Mil. The current Total Operating Expense is $0.99 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Lattice Biologics (LBLTF), the current Total Operating Expense is $0.99 Mil as of Jun. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lattice Biologics Business Description

Address 512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The company's products include ADM dermis, DBM Putty, Bone scaffold, and others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.